Stay updated with breaking news from Expanded Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharmaceutical companies that have provided investigational drugs to patients under the Right to Try law should be prepared to comply with the U.S. Food and Drug Administration’s...
Walgreens says it will not start selling an abortion pill in 20 states that had warned of legal consequences if it did so. The drugstore chain’s announcement Thursday signals that access to mifepristone may not expand as broadly as federal regulators intended in January, when they finalized a rule change allowing more pharmacies to provide the pill. The U.S. Food and Drug Administration approved mifepristone in 2000 to end pregnancy, when used in combination with a second drug, misoprostol.
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the fourth quarter and full year ended...
Editor’s Note: America spends more on health care per person than any other developed country, only to have the lowest life expectancy among them. Despite our expenditures—now one out...
/PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "E-Clinical Solutions Market" The report offers an extensive analysis of...